AT325614B - Verfahren zur herstellung von neuen 2-amino-4,5-dihydropyridin-3,5-dicarbonsäureestern - Google Patents

Verfahren zur herstellung von neuen 2-amino-4,5-dihydropyridin-3,5-dicarbonsäureestern

Info

Publication number
AT325614B
AT325614B AT196973A AT196973A AT325614B AT 325614 B AT325614 B AT 325614B AT 196973 A AT196973 A AT 196973A AT 196973 A AT196973 A AT 196973A AT 325614 B AT325614 B AT 325614B
Authority
AT
Austria
Prior art keywords
dihydropyridine
amino
new
production
acid esters
Prior art date
Application number
AT196973A
Other languages
English (en)
Other versions
ATA196973A (de
Original Assignee
Bayer Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from DE2210650A external-priority patent/DE2210650C3/de
Priority claimed from DE19722260860 external-priority patent/DE2260860A1/de
Application filed by Bayer Ag filed Critical Bayer Ag
Publication of ATA196973A publication Critical patent/ATA196973A/de
Application granted granted Critical
Publication of AT325614B publication Critical patent/AT325614B/de

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/04Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • A61P11/08Bronchodilators
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00Drugs for disorders of the urinary system
    • A61P13/02Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00Drugs for genital or sexual disorders; Contraceptives
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/06Antihyperlipidemics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/06Antiarrhythmics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/08Vasodilators for multiple indications
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/10Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/12Antihypertensives
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D211/00Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/80Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
    • C07D211/84Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen directly attached to ring carbon atoms
    • C07D211/90Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D405/00Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/04Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings directly linked by a ring-member-to-ring-member bond

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Pulmonology (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Pyridine Compounds (AREA)
AT196973A 1972-03-06 1973-03-06 Verfahren zur herstellung von neuen 2-amino-4,5-dihydropyridin-3,5-dicarbonsäureestern AT325614B (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE2210650A DE2210650C3 (de) 1972-03-06 1972-03-06 2-Amino-6-alkoxy-4,5-dihydropyridin-3,5-dicarbonsäureester, Verfahren zu ihrer Herstellung sowie diese enthaltende Arzneimittel
DE19722260860 DE2260860A1 (de) 1972-12-13 1972-12-13 Verfahren zur herstellung von neuen 2-amino-6-alkylmercapto-4,5-dihydropyridinen sowie ihre verwendung als antihypertensiva

Publications (2)

Publication Number Publication Date
ATA196973A ATA196973A (de) 1975-01-15
AT325614B true AT325614B (de) 1975-10-27

Family

ID=25762843

Family Applications (1)

Application Number Title Priority Date Filing Date
AT196973A AT325614B (de) 1972-03-06 1973-03-06 Verfahren zur herstellung von neuen 2-amino-4,5-dihydropyridin-3,5-dicarbonsäureestern

Country Status (16)

Country Link
US (1) US3876646A (de)
JP (1) JPS5626658B2 (de)
AT (1) AT325614B (de)
CA (1) CA985685A (de)
CH (1) CH580591A5 (de)
CS (1) CS179980B2 (de)
DD (1) DD106832A5 (de)
DK (1) DK135714C (de)
ES (1) ES412320A1 (de)
FR (1) FR2183673B1 (de)
GB (1) GB1374551A (de)
HU (1) HU167088B (de)
IE (1) IE37367B1 (de)
IL (1) IL41666A (de)
NL (1) NL7303134A (de)
SE (1) SE384206B (de)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3951993A (en) * 1972-03-06 1976-04-20 Bayer Aktiengesellschaft 2-Amino-4,5-dihydropyridine derivatives and process for their preparation

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE1923990C3 (de) * 1969-05-10 1978-11-23 Bayer Ag Verfahren zur Herstellung von N-substituierten M-Dihydropyridin-S.S-dicarbonsäureestern
DE2013431C3 (de) * 1970-03-20 1979-12-20 Bayer Ag, 5090 Leverkusen 4-Azidophenyl-l,4-dihydropyridin-3,5-dicarbonsäureester
DE1963186C3 (de) * 1969-12-17 1979-02-15 Bayer Ag, 5090 Leverkusen Schwefelhaltige 1,4-Dihydropyridin-33-dicarbonsäureester
ZA7152B (en) * 1970-01-24 1971-10-27 Bayer Ag New pharmaceutically active 1,4-dihydropyridines
DE2117571C3 (de) * 1971-04-10 1979-10-11 Bayer Ag, 5090 Leverkusen Unsymmetrische 1,4-Dihydropyridin-33-dicarbonsäureester, Verfahren zu ihrer Herstellung sowie ihre Verwendung als Arzneimittel
DE2117572C3 (de) * 1971-04-10 1980-03-20 Bayer Ag, 5090 Leverkusen Unsymmetrische 1,4-Dihydropyridin ^-dicarbonsäureester, Verfahren zu ihrer Herstellung sowie ihre Verwendung als Arzneimittel

Also Published As

Publication number Publication date
JPS4899180A (de) 1973-12-15
FR2183673B1 (de) 1976-12-03
GB1374551A (en) 1974-11-20
CA985685A (en) 1976-03-16
DD106832A5 (de) 1974-07-05
ES412320A1 (es) 1976-04-16
ATA196973A (de) 1975-01-15
JPS5626658B2 (de) 1981-06-19
US3876646A (en) 1975-04-08
IE37367L (en) 1973-09-06
IE37367B1 (en) 1977-07-06
IL41666A0 (en) 1973-05-31
SE384206B (sv) 1976-04-26
CS179980B2 (en) 1977-12-30
CH580591A5 (de) 1976-10-15
DK135714C (da) 1977-11-14
IL41666A (en) 1976-02-29
FR2183673A1 (de) 1973-12-21
DK135714B (da) 1977-06-13
HU167088B (de) 1975-08-28
NL7303134A (de) 1973-09-10

Similar Documents

Publication Publication Date Title
AT319969B (de) Verfahren zur Herstellung von neuen Diphosphinsäureestern
AT338425B (de) Verfahren zur herstellung von neuen 7-acylamido-3-cephem-4-carbonsaurederivaten
AT347612B (de) Verfahren zur herstellung von neuen pregnan-21- saeure-derivaten
AT327194B (de) Verfahren zur herstellung von neuen 2-alkylamino-dihydropyridinen
AT321942B (de) Verfahren zur herstellung von neuen o-äthyl-s-n-propyl-o-vinyl- -thionothiolphosphorsäureestern
AT327942B (de) Verfahren zur herstellung von neuen n-phenyl-carbaminsaure- beta -phenoxyathylestern
AT327384B (de) Verfahren zur herstellung von neuen fusidinsaurederivaten
AT331425B (de) Verfahren zur herstellung von neuen d-2-halogen-6-methyl-8-subst.-methylergolinen
AT327376B (de) Verfahren zur herstellung von neuen 7-acylamido-7-methoxy-cephemcarbonsaurederivaten
AT323420B (de) Verfahren zur herstellung von poly-alpha-oxy-acrylsäure
ATA532473A (de) Verfahren zur herstellung von 7-amino-desacetoxy-cephalosporansaure
AT325614B (de) Verfahren zur herstellung von neuen 2-amino-4,5-dihydropyridin-3,5-dicarbonsäureestern
AT334347B (de) Verfahren zur herstellung von neuen phenoxymalonsaureestern
AT323149B (de) Verfahren zur herstellung von neuen 5-aroylpyrrolcarbonsäureglycerinestern
AT327175B (de) Verfahren zur herstellung von neuen diacetoxybenzoesaureestern
AT340608B (de) Verfahren zur herstellung von neuen 9-desoxy-prosta-5,9, (10),13-triensaurederivaten
CH548396A (de) Verfahren zur herstellung von neuen d-6-methyl-8-ergolin-(i)-ylessigsaeureamiden.
AT338230B (de) Verfahren zur herstellung von neuen, optisch aktiven 5-hydroxycyclopent-2-enessigsaureestern
ATA569773A (de) Verfahren zur herstellung von neuen 7beta-amino-cepham-3-on-4-carbonsaureverbindungen
AT333723B (de) Verfahren zur herstellung von neuen phenoxyalkancarbonsaurethiolestern
AT329541B (de) Verfahren zur herstellung von neuen 3-alkoxy-5-subst. phenylessigsauren
AT323342B (de) Verfahren zur herstellung von neuen pregnansäure-derivaten
AT341122B (de) Verfahren zur herstellung von neuen prostanoesaurederivaten
AT342217B (de) Verfahren zur herstellung von neuen prostanoesaurederivaten
ATA123975A (de) Verfahren zur herstellung von neuen prostanoesaurederivaten

Legal Events

Date Code Title Description
ELJ Ceased due to non-payment of the annual fee